Company: IMNN
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001641172-25-013068
Chunk: 27

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 27
---
 Audit Committee

Mr. James E. Dentzer (Chairman)

Mr. Frederick J. Fritz

Ms. Christine A. Pellizzari

This report does not constitute “soliciting material” and shall not be deemed filed or incorporated by reference into any filing under the Securities Act of 1933 or under the Securities Exchange Act of 1934, except to the extent we specifically incorporate this report by reference and shall not otherwise be deemed filed under such Acts.

| 23 |

<div align='center'>EXECUTIVE AND DIRECTOR COMPENSATION</div>

Compensation of Executive Officers

This section discusses the material components of the executive compensation program for our executive officers who are named in the “2024 Summary Compensation Table” below. In 2024, our “named executive officers” and their positions were as follows:

| ● | Stacy                                                                                         
 Lindborg, our President and Chief Executive Officer;                                          |
| ● | Michael                                                                                       
 Tardugno, our Executive Chairman and former President and Chief Executive Officer;            |
| ● | Corinne                                                                                       
 Le Goff, our former President and Chief Executive Officer;                                    |
| ● | Khursheed                                                                                     
 Anwer, our Executive Vice President and Chief Scientific Officer;                             |
| ● | David                                                                                         
 Gaiero, our Chief Financial Officer; and                                                      |
| ● | Jeffrey                                                                                       
 Church, our former Executive Vice President, Chief Financial Officer and Corporate Secretary. |

2024 Summary Compensation Table

The following table sets forth information regarding the total compensation for services rendered in all capacities during the years ended December 31, 2024 and 2023, awarded to, paid to, or earned by each “Named Executive Officer.”. All compensation awarded to, earned by, or paid to IMUNON’s Named Executive Officers is included in the table below for the years ended December 31, 2024 and 2023:

| Name and Principal                      
 Position                                |     | Year |      |     | Salary |         |     | Bonus |   |     | Stock      
 Awards (1) |        |     | Option 
 Awards 
 (2)    |         |     | Non-Equity     
 Incentive Plan 
 Compensation   
 (3)            |         |     | All          
 Other        
 Compensation 
 (4)          |         |     | Total 
 ($)   |           |
|:----------------------------------------|:----|:-----|-----:|:----|:-------|--------:|:----|:------|: